Qian Shi

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.345Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Inflammation, physical activity, and disease-free survival in stage III colon cancer: Cancer and Leukemia Group B–Southwest Oncology Group 80702 (Alliance)

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae203

Top 61%

0.241DataRank

Top 61%4 citations

Chao Ma, Qian Shi, Félix Couture, Philip Kuebler, Pankaj Kumar +8 more

Papers

Driven by 46 papers — median percentile 30. Top paper: “Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy (RT) for borderline resectable (BR) adenocarcinoma of the pancreas.”.

Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy (RT) for borderline resectable (BR) adenocarcinoma of the pancreas.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.377

N/A

5.8DataRank · unranked

144 citations

Qian Shi, Jeffrey P. Meyers, Joseph M. Herman, Michael Choung, Brian M. Wolpin +13 more

Preoperative Treatment of Locally Advanced Rectal Cancer

New England Journal of Medicine(2023)10.1056/nejmoa2303269

N/A

5.6DataRank · unranked

460 citations

Qian Shi, Martin R. Weiser, Marc J. Gollub, Leonard B. Saltz, Benjamin Musher +20 more

Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in PIK3CA-Activated Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance)

Journal of Clinical Oncology(2024)10.1200/jco.23.01680

N/A

0.944DataRank · unranked

25 citations

Tyler S. Twombly, Chao Ma, Qian Shi, Koichiro Haruki, Kenji Fujiyoshi +17 more

Postoperative Adverse Events Following Neoadjuvant Therapy and Surgery for Borderline Resectable Pancreatic Cancer in a Phase 2 Clinical Trial (Alliance A021501)

Annals of Surgical Oncology(2024)10.1245/s10434-024-15670-6

N/A

0.381DataRank · unranked

6 citations

Tyler Zemla, Qian Shi, Diana Segovia, Syed A. Ahmad, Eileen M. O’Reilly +3 more

A randomized trial of consolidation-targeted adjuvant therapy with encorafenib and cetuximab versus usual care for patients with stage II/III BRAF V600E colon cancer: Alliance for Clinical Trials in Oncology A022004.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps3641

N/A

0.353DataRank · unranked

6 citations

Qian Shi, Amylou C. Dueck, Elie G. Dib, Syed Mohammad Ali Kazmi, Olatunji B. Alese +6 more

Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur)

BMC Cancer(2024)10.1186/s12885-024-11899-2

N/A

0.324DataRank · unranked

4 citations

Eric D. Miller, Qian Shi, Jesse G. Dixon, Sepideh Gholami, Sarah B. White +13 more

Utilizing Patient Input in Rectal Cancer Trial Design

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf074

N/A

0.241DataRank · unranked

4 citations

Wini Zambare, Manju George, Reese Garcia, Phuong Gallagher, Caleah Kitchens +22 more

Inflammation, physical activity, and disease-free survival in stage III colon cancer: Cancer and Leukemia Group B–Southwest Oncology Group 80702 (Alliance)

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae203

Top 61%

0.241DataRank

Top 61%4 citations

Chao Ma, Qian Shi, Félix Couture, Philip Kuebler, Pankaj Kumar +8 more

CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma

Cancer Research Communications(2024)10.1158/2767-9764.crc-22-0516

N/A

0.216DataRank · unranked

2 citations

Susan M. Geyer, Andrew B. Nixon, Federico Innocenti, Qian Shi, Priya Kumthekar +16 more

Genetic Predictors of Severe Skin Toxicity in Patients with Stage III Colon Cancer Treated with Cetuximab: NCCTG N0147 (Alliance)

Cancer Epidemiology Biomarkers & Prevention(2020)10.1158/1055-9965.epi-20-1274

N/A

0.216DataRank · unranked

2 citations

Xinwei Hua, Tabitha A. Harrison, Barbara L. Banbury, Jeroen R. Huyghe, Wei Sun +13 more

Associations between early tumor shrinkage/depth of response and survival from the ARCAD database

JNCI Cancer Spectrum(2025)10.1093/jncics/pkaf042

Top 78%

0.104DataRank

Top 78%1 citations

Yuriko Takeda, Toshihiro Misumi, Tomomi Nishikawa, Masashi Wakabayashi, Kentaro Yamazaki +14 more

Genetically Predicted Circulating C-Reactive Protein Concentration and Colorectal Cancer Survival: A Mendelian Randomization Consortium Study

Cancer Epidemiology Biomarkers & Prevention(2021)10.1158/1055-9965.epi-20-1848

N/A

0DataRank · unranked

10 citations

James Y. Dai, Sara Lindström, Tabitha A. Harrison, Yi Lin, Steven R. Alberts +29 more

Alliance/CALGB 80802: Impact of hepatitis C (HCV) on doxorubicin (DO) + sorafenib (S) versus S in patients (pts) with advanced hepatocellular carcinoma (aHCC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.325

N/A

0DataRank · unranked

2 citations

Susan M. Geyer, Andrew B. Nixon, Federico Innocenti, Qian Shi, Sawyer Jacobson +12 more

Radiomic signatures to predict survival in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib +/- doxorubicin: Correlative science from CALGB 80802 (Alliance).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.343

N/A

0DataRank · unranked

1 citations

Susan M. Geyer, Andrew B. Nixon, Federico Innocenti, Qian Shi, Sawyer Jacobson +12 more

Association of plasma adiponectin with tumor infiltrating lymphocytes and survival in patients with stage III colon cancer (NCCTG N0147; Alliance).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.3591

N/A

0DataRank · unranked

1 citations

Qian Shi, Thomas C. Smyrk, Richard M. Goldberg, Steven J. Cohen, Sharlene Gill +9 more

Prognostic value of tumor deposits in stage III colon cancer patients, a post-hoc analysis of CALGB/SWOG 80702 phase III study.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.10

N/A

0DataRank · unranked

0 citations

Qian Shi, Jeffrey P. Meyers, Zhaohui Jin, Magali Svrcek, Charles S. Fuchs +14 more

Antitumor agents 269. Non-aromatic ring-A neotanshinlactone analog, TNO, as a new class of potent antitumor agents

UNC Libraries(2021)10.17615/9cgp-ks90

N/A

0DataRank · unranked

0 citations

Kuo Hsiung Lee, Pei Wu, Susan L. Morris‐Natschke, Kenneth F. Bastow, Qian Shi +2 more

Outcomes following FGFR Inhibitor Therapy in Patients with Cholangiocarcinoma

Targeted Oncology(2022)10.1007/s11523-022-00914-w

N/A

0DataRank · unranked

8 citations

Vanessa Wookey, Tyler Zemla, Qian Shi, Zhaohui Jin, Steven R. Alberts +7 more

Assessing surrogacy using restricted mean survival time ratio for overall survival in non-small cell lung cancer immunotherapy studies

Chinese Clinical Oncology(2022)10.21037/cco-21-110

N/A

0DataRank · unranked

4 citations

Guangyu Yang, Jcm Ho, Tiffany H Leung, Qian Shi, Chen Hu +3 more

Predictive Polygenic Score for Outcome after First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients Using Supervised Principal Component Analysis

Cancer Epidemiology Biomarkers & Prevention(2022)10.1158/1055-9965.epi-22-0320

N/A

0DataRank · unranked

4 citations

Dominic Edelmann, Federico Canzian, Tabitha A. Harrison, Xinwei Hua, Qian Shi +11 more

Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer

European Urology Oncology(2023)10.1016/j.euo.2023.11.014

N/A

0DataRank · unranked

18 citations

Fadi Taza, Navonil De Sarkar, Alok K. Tewari, Syed Arsalan Ahmed Naqvi, Irbaz Bin Riaz +32 more

Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0447

N/A

0DataRank · unranked

10 citations

Chao Ma, Chen Yuan, Qian Shi, Brian M. Wolpin, Yin Zhang +19 more

Association between physical activity and the time course of cancer recurrence in stage III colon cancer

British Journal of Sports Medicine(2023)10.1136/bjsports-2022-106445

N/A

0DataRank · unranked

26 citations

Chao Ma, Qian Shi, Donna Niedzwiecki, Tyler Zemla, Félix Couture +9 more

Physical activity in recurrent colon cancer: Cancer and Leukemia Group B/SWOG 80702 (Alliance)

Cancer(2023)10.1002/cncr.35007

N/A

0DataRank · unranked

4 citations

Chao Ma, Qian Shi, Tyler Zemla, Félix Couture, Philip Kuebler +11 more

Genome‐wide study of genetic polymorphisms predictive for outcome from first‐line oxaliplatin‐based chemotherapy in colorectal cancer patients

International Journal of Cancer(2023)10.1002/ijc.34663

N/A

0DataRank · unranked

4 citations

Dominic Edelmann, Federico Canzian, Petra Seibold, Tabitha A. Harrison, Xinwei Hua +14 more

NCI Rectal-Anal Task Force consensus recommendations for design of clinical trials in rectal cancer

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad143

N/A

0DataRank · unranked

2 citations

Rebecca C. Auer, May Cho, N.A. Dasari, Cynthia Davies-Venn, Cathy Eng +36 more

Alliance A022104/NRG-GI010: A randomized phase II trial testing the efficacy of triplet versus doublet chemotherapy to achieve clinical complete response in patients with locally advanced rectal cancer—The Janus Rectal Cancer trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps3640

N/A

0DataRank · unranked

21 citations

Arvind Dasari, Qian Shi, Julio García‐Aguilar, Hanna K. Sanoff, Thomas J. George +13 more

PROSPECT: A randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total mesorectal excision (TME) for treatment of locally advanced rectal cancer (LARC) (Alliance N1048).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.17_suppl.lba2

N/A

0DataRank · unranked

18 citations

Qian Shi, Martin R. Weiser, Marc J. Gollub, Leonard B. Saltz, Benjamin Musher +15 more

Alliance A022101: A pragmatic, randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: Evaluating Radiation, Ablation, and Surgery (ERASur).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps3629

N/A

0DataRank · unranked

1 citations

Paul B. Romesser, Qian Shi, Jesse G. Dixon, Sepideh Gholami, Sarah B. White +12 more

Alliance for Clinical Trials in Oncology (Alliance) trial A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur)

Research Square(2023)10.21203/rs.3.rs-3773522/v1

N/A

0DataRank · unranked

1 citations

Eric D. Miller, Qian Shi, Jesse G. Dixon, Sepideh Gholami, Sarah B. White +13 more

Use of Deep Learning to Evaluate Tumor Microenvironmental Features for Prediction of Colon Cancer Recurrence

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0031

N/A

0DataRank · unranked

15 citations

Garth D. Nelson, Bahar Saberzadeh-Ardestani, Diana I. Segovia, Rondell P. Graham, Christina Wu +22 more

Alliance A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer—Evaluating radiation, ablation, and surgery (ERASur).

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.tps3633

N/A

0DataRank · unranked

0 citations

Kathryn Hitchcock, Qian Shi, Jesse G. Dixon, Sepideh Gholami, Sarah B. White +12 more

Sex differences in chemotherapy completion, toxicities, and survival in colon cancer: an analysis of 2201 patients from CALGB/SWOG 80702 (Alliance)

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf281

N/A

0DataRank · unranked

4 citations

Qian Shi, Anthony F. Shields, Xiaonan Xue, Thomas E. Rohan, Chaoyuan Kuang +12 more

Alliance A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer—Evaluating radiation, ablation, and surgery (ERASur).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.tps3634

N/A

0DataRank · unranked

0 citations

Kathryn Hitchcock, Qian Shi, Jesse G. Dixon, Sepideh Gholami, Sarah B. White +12 more

A new prognostic and predictive tool for shared decision making in stage III colon cancer

European Journal of Cancer(2020)10.1016/j.ejca.2020.07.031

N/A

0DataRank · unranked

69 citations

Alberto Puccini, Qian Shi, Axel Grothey, Thierry André, Anthony F. Shields +6 more

Trials in progress: Alliance A022104/NRG-GI010—A randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer (LARC; the Janus Rectal Cancer trial).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.tps3650

N/A

0DataRank · unranked

0 citations

Qian Shi, Arvind Dasari, Julio García‐Aguilar, Hanna K. Sanoff, Thomas J. George +15 more

Modeling cancer clinical trials using HL7 FHIR to support downstream applications: A case study with colorectal cancer data

International Journal of Medical Informatics(2020)10.1016/j.ijmedinf.2020.104308

N/A

0DataRank · unranked

29 citations

Daniel J. Stone, Deepak Sharma, Andrew Wen, Chen Wang, Yue Yu +6 more

Summary of the 2019 Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2020.06.011

N/A

0DataRank · unranked

6 citations

Alan Howard, David Avigan, Manisha Bhutani, Adam D. Cohen, Luciano J. Costa +22 more

Overall survival (OS) and long-term disease-free survival (DFS) of three versus six months of adjuvant (adj) oxaliplatin and fluoropyrimidine-based therapy for patients (pts) with stage III colon cancer (CC): Final results from the IDEA (International Duration Evaluation of Adj chemotherapy) collaboration.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4004

N/A

0DataRank · unranked

36 citations

Thierry André, Jeffrey A. Meyerhardt, Axel Grothey, Timothy Iveson, Takayuki Yoshino +15 more

Celecoxib in addition to standard adjuvant therapy with 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX) in stage III colon cancer: Results from CALGB/SWOG 80702.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4003

N/A

0DataRank · unranked

3 citations

Qian Shi, Charles S. Fuchs, Donna Niedzwiecki, Tyler Zemla, Priya Kumthekar +15 more

Clinicopathological and molecular biological characteristics of early-onset stage II/III colorectal adenocarcinoma: An analysis of 25 studies with 47,184 patients (pts) in the adjuvant colon cancer end points (ACCENT) database.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4099

N/A

0DataRank · unranked

1 citations

Jesse G. Dixon, Hiral D. Parekh, Steven R. Alberts, Greg Yothers, Carmen J. Allegra +15 more

Tumor-infiltrating lymphocytes and tumor budding refine prognostication in patients with low- and high-risk stage III colon cancers (NCCTG N0147)[Alliance].

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4065

N/A

0DataRank · unranked

0 citations

Hee Eun Lee, Nathan R. Foster, Qian Shi, Steven R. Alberts, Thomas C. Smyrk +2 more

Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma

American Journal of Hematology(2021)10.1002/ajh.26149

N/A

0DataRank · unranked

22 citations

Lasse Hjort Jakobsen, Raphael Mwangi, Norbert Schmitz, Umar Farooq, C. R. Flowers +18 more

Chemoradiation and Local Excision Versus Total Mesorectal Excision for T2N0 Rectal Cancer

Annals of Surgery(2021)10.1097/sla.0000000000005052

N/A

0DataRank · unranked

20 citations

Maxime J.M. van der Valk, Y.H.M. Claassen, Qian Shi, Maria Widmar, E Bastiaannet +3 more

Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab187

N/A

0DataRank · unranked

16 citations

Mohamed E. Salem, Jesse G. Dixon, Zhaohui Jin, Romain Cohen, Aimery DeGramont +16 more

Association of Adiponectin and Vitamin D With Tumor Infiltrating Lymphocytes and Survival in Stage III Colon Cancer

JNCI Cancer Spectrum(2021)10.1093/jncics/pkab070

N/A

0DataRank · unranked

9 citations

Qian Shi, Thomas C. Smyrk, Richard M. Goldberg, Steven J. Cohen, Sharlene Gill +9 more

Qian Shi

Indexed papers

Top data-sharing exemplar

Papers